Changing the paradigm: Personalised antibiotics dosing for critically ill

010318_MT_bacteria_feat

(Prof Jeffery Lipman)

Interesting and thought provoking talk about how we might be inappropriately dosing antibiotics in our critically ill patients.

pK changes in ICU patients (also changes during the course of their ICU admission). Hence dosing is complex and studies confirm that it is very variable across ICUs.

 

IMG_0084 IMG_0087 IMG_0088

 

 

pD properties of antibacterials and hence kill characteristics different across the various classes of antibiotics.

IMG_0091 IMG_0093 IMG_0095

 

 

Proposed solutions:

IMG_0097

 

The problem is that trials which had looked at continuous vs intermittent dosing of antibiotics e.g. BLINGs and BLISS, have focussed on clinical cure rather than mortality. Watch out for BLING3